{
  "id": "Ex079",
  "type": "Example",
  "informationId": {
    "id": "CritAssess356",
    "type": "CriterionAssessment",
    "criterion": {
      "id": "Crit329",
      "type": "Criterion",
      "label": "BP6",
      "description": "Reputable source recently reports variant as benign, but the evidence is not available to the laboratory to perform an independent evaluation",
      "defaultStrength": {
        "id": "ELSID140",
        "type": "EvidenceLineStrength",
        "label": "Benign Supporting"
      }
    },
    "variant": {
      "id": "CanAll115",
      "type": "CanonicalAllele",
      "preferredCtxAllele": {
        "id": "CtxAll121",
        "type": "ContextualAllele",
        "producedBy": null,
        "relatedCanonicalAllele": "CanAll115",
        "alleleName": "NM_000059.3(BRCA2):c.-26G>A"
      }
    },
    "condition": [
      {
        "id": "GenCond043",
        "type": "GeneticCondition",
        "disease": [
          {
            "id": "DisID153",
            "type": "Disease",
            "label": "Breast-Ovarian Cancer, Familial, Susceptibility To, 2"
          }
        ]
      }
    ],
    "outcome": {
      "id": "CEID074",
      "type": "CriterionEvaluation",
      "label": "Met"
    },
    "evidenceLine": [
      {
        "id": "EvLn098",
        "type": "EvidenceLine",
        "evidenceItem": [
          {
            "id": "VarInterp256",
            "type": "VariantInterpretation",
            "variant": {
              "id": "CanAll115",
              "type": "CanonicalAllele",
              "preferredCtxAllele": {
                "id": "CtxAll121",
                "type": "ContextualAllele",
                "producedBy": null,
                "relatedCanonicalAllele": "CanAll115",
                "alleleName": "NM_000059.3(BRCA2):c.-26G>A"
              }
            },
            "condition": [
              {
                "id": "GenCond043",
                "type": "GeneticCondition",
                "disease": [
                  {
                    "id": "DisID153",
                    "type": "Disease",
                    "label": "Breast-Ovarian Cancer, Familial, Susceptibility To, 2"
                  }
                ]
              }
            ],
            "outcome": {
              "id": "SIGID032",
              "type": "Significance",
              "label": "Benign"
            },
            "description": "classified by Sharing Clinical Reports Project."
          }
        ]
      }
    ],
    "contribution": [
      {
        "type": "Contribution",
        "agent": {
          "id": "Agent007",
          "type": "Agent",
          "label": "Stefan DiMarino"
        },
        "contributionDate": "10/10/16 8:02 AM",
        "contributionRole": {
          "id": "CRID193",
          "type": "ContributoryRole",
          "label": "assessor role"
        }
      }
    ]
  },
  "index": 2,
  "author": "#N/A",
  "description": "Variant: NM_000059.3(BRCA2):c.-26G>A\n\nVariant has been classified as “Benign” by Sharing Clinical Reports Project (SCV000189291.1)\n\nhttp://www.ncbi.nlm.nih.gov/clinvar/variation/125965/#clinical-assertions\n\nSharing Clinical Reports Project are reports from Myriad - who are considered experts in this field but do not share their evidence - only their interpretation. \n\n(Note: this is the exact scenarios this rule was written for - but people are being very liberal in applying this rule) "
}
